Your browser doesn't support javascript.
loading
Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma.
Han, Lu; Zhang, Ji-Shuai; Zhou, Jian; Zhou, Ke-Shu; Xu, Ben-Ling; Li, Lin-Lin; Fang, Bai-Jun; Yin, Qing-Song; Zhu, Xing-Hu; Zhou, Hu; Wei, Xu-Dong; Su, Hong-Chang; Zhang, Bing-Xiang; Wang, Ya-Nan; Xiang, Bin; Gao, Quan-Li; Song, Yong-Ping.
Afiliação
  • Han L; Department of Immunology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Zhang JS; The Shenzhen Pregene Biopharma Company, Ltd., Shenzhen, 518118, Guangdong, China.
  • Zhou J; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Zhou KS; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Xu BL; Department of Immunology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Li LL; Department of Immunology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Fang BJ; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Yin QS; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Zhu XH; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Zhou H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Wei XD; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
  • Su HC; The Shenzhen Pregene Biopharma Company, Ltd., Shenzhen, 518118, Guangdong, China.
  • Zhang BX; The Shenzhen Pregene Biopharma Company, Ltd., Shenzhen, 518118, Guangdong, China.
  • Wang YN; The Shenzhen Pregene Biopharma Company, Ltd., Shenzhen, 518118, Guangdong, China.
  • Xiang B; The Shenzhen Pregene Biopharma Company, Ltd., Shenzhen, 518118, Guangdong, China.
  • Gao QL; Department of Immunology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China. zlyygql0855@zzu.edu.cn.
  • Song YP; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450008, Henan, China. songyongping001@126.com.
Leukemia ; 35(10): 3002-3006, 2021 10.
Article em En | MEDLINE | ID: mdl-34031533
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Cadeias Pesadas de Imunoglobulinas / Resistencia a Medicamentos Antineoplásicos / Antígeno de Maturação de Linfócitos B / Anticorpos de Cadeia Única / Mieloma Múltiplo / Recidiva Local de Neoplasia Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Cadeias Pesadas de Imunoglobulinas / Resistencia a Medicamentos Antineoplásicos / Antígeno de Maturação de Linfócitos B / Anticorpos de Cadeia Única / Mieloma Múltiplo / Recidiva Local de Neoplasia Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article